title: Neonatal screening for congenital adrenal hyperplasia in Taiwan: a pilot study.
abstract: OBJECTIVE
  Congenital adrenal hyperplasia (CAH) is an autosomal recessive disorder with defects in steroidogenesis. Its wide and non-specific clinical spectrum poses problems for early diagnosis. Without a screening program, affected newborns may be missed, even though they have a life-threatening illness. The purpose of this study was to survey the prevalence and phenotype of CAH in Taiwan by neonatal screening.
  
  
  METHODS
  From March 1, 2000, to August 31, 2001, 192,687 capillary blood spots were collected nationwide. Enzyme-linked immunosorbent assay (ELISA) was used to quantitatively measure 17-hydroxyprogesterone (17-OHP) in all specimens.
  
  
  RESULTS
  Thirteen cases of CAH (7 female and 6 male) were detected, resulting in an estimated prevalence of 1:14,822. Nine patients (69%) had salt-wasting CAH and four (31%) had simple virilizing CAH. All cases were identified before clinical diagnosis, and also before the development of adrenal crisis.
  
  
  CONCLUSIONS
  This study estimated that 20 babies with CAH are born each year in Taiwan. A nationwide neonatal screening program is the only way to provide early diagnosis and prompt treatment. This would save lives and enhance the health of affected infants.
authors.affiliation: Department of Pediatrics, Buddhist Tzu-Chi General Hospital, Hualien.
authors.forename: Shao-Yin
authors.initials: SY
authors.lastname: Chu
authors.forename: Wen-Yu
authors.initials: WY
authors.lastname: Tsai
authors.forename: Li-Hsin
authors.initials: LH
authors.lastname: Chen
authors.forename: Ming-Lee
authors.initials: ML
authors.lastname: Wei
authors.forename: Yin-Hsiu
authors.initials: YH
authors.lastname: Chien
authors.forename: Wuh-Liang
authors.initials: WL
authors.lastname: Hwu
mesh_terms: D019326:17-alpha-Hydroxyprogesterone / Q000097:blood; D000312:Adrenal Hyperplasia, Congenital / Q000175:diagnosis*; D004797:Enzyme-Linked Immunosorbent Assay; D005260:Female; D006801:Humans; D007231:Infant, Newborn; D008297:Male; D015997:Neonatal Screening; D010865:Pilot Projects
chemical_list: D019326:17-alpha-Hydroxyprogesterone